Financials
- Market Capitalization 362.19 M
- Employee 45
- Founded 2019
- CEO N/A
- Website www.x4pharma.com
- Headquarter Delaware, United States
- FIGI BBG001J1CYH8
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3163 | FENC Fennec Pharmaceuticals Inc. - Common Stock | 10.62 USD | -4.84% | +3.71% | +14.07% | +20.27% | 368.91 M USD | ||
| 3165 | LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.69 USD | +1.52% | -7.31% | -0.64% | +12.74% | 368.27 M USD | ||
| 3188 | PRLD Prelude Therapeutics Incorporated - Common Stock | 4.50 USD | +2.51% | -10.89% | +2.97% | +455.56% | 358.40 M USD | ||
| 3199 | PALI Palisade Bio, Inc. - Common Stock | 2.04 USD | +5.70% | +3.03% | +21.43% | +20.00% | 354.10 M USD |
Frequently asked questions about X4 Pharmaceuticals, Inc. - Common Stock
What is the X4 Pharmaceuticals, Inc. - Common Stock stock price today?
The current price of X4 Pharmaceuticals, Inc. - Common Stock (XFOR) is 3.84. Over the past 24 hours, the stock has changed by -4.48%. Follow the XFOR chart for real-time price dynamics.
What is the stock ticker of X4 Pharmaceuticals, Inc. - Common Stock?
X4 Pharmaceuticals, Inc. - Common Stock trades under the ticker XFOR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is X4 Pharmaceuticals, Inc. - Common Stock stock going up?
XFOR has changed by -1.79% over the last week, -6.34% over the last month, and +29.29% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was X4 Pharmaceuticals, Inc. - Common Stock net income for the last quarter?
X4 Pharmaceuticals, Inc. - Common Stock reported net income of -20.24 M for the last quarter. The previous quarter showed -23.93 M, which means net income changed by +15.40%.
How many employees does X4 Pharmaceuticals, Inc. - Common Stock have?
As of the latest available data, X4 Pharmaceuticals, Inc. - Common Stock has 45 employees. Workforce size can provide additional context about the company's scale and operations.
What is X4 Pharmaceuticals, Inc. - Common Stock EBITDA?
X4 Pharmaceuticals, Inc. - Common Stock EBITDA is -4.88 M, and its EBITDA margin is -195.12%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy X4 Pharmaceuticals, Inc. - Common Stock stock?
You can buy X4 Pharmaceuticals, Inc. - Common Stock (XFOR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in X4 Pharmaceuticals, Inc. - Common Stock stock?
Investing in X4 Pharmaceuticals, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the XFOR chart and related analysis on metatrader.com as part of your research.